-
BOC/BOA 2024 | Professor Tiejun Gong: Interpretation of Three Major Studies in Hematologic Oncology
From July 5th to 7th, the highly anticipated 2024 Annual Progress Seminar in Clinical Oncology in China (BOC) and Best of ASCO 2024 China were grandly held in Guangzhou. Based on the actual situation of cancer incidence in China, the conference specially invited authoritative experts in the field of oncology and carefully selected outstanding papers…
-
SOHO 2024 | Dr. Astrid Pavlovsk Discusses the Current Status and Prospects of the Diagnosis and Treatment of Aggressive Lymphomas
Aggressive lymphomas progress rapidly and are prone to relapse, with existing treatments still failing to achieve a satisfactory cure rate. Particularly for high-risk patient groups, the demand for precise and efficient treatments is more urgent. The 12th Annual Meeting of the Society for Hematologic Oncology (SOHO 2024) was held in Houston, USA, from September 4th…
-
Dr. Bo Feng: Classification and Differentiation of Hepatic Vascular Lesions
As the largest digestive gland in the body, the liver has a unique dual blood supply, including inflow vessels (hepatic artery and portal vein) and outflow vessels (hepatic veins). The…
-
CCML 2024 | Establishing China’s Clinical Microbiology Standards, Elevating Infectious Disease Science
1. Infectious Diseases Frontier: Could you give us an overview of the CCML conference’s background, history, and highlights this year? Dr. Qiwen Yang: The CCML conference, organized by the Clinical…
-
EHA Expert Interview | Professor Hongyan Tong: New MDS Classification and Advances in the MDS-f Subtype
The 29th European Hematology Association (EHA) Annual Meeting was grandly held in Madrid, Spain, from June 13-16, 2024. As the largest international conference in the field of hematology in Europe, it attracts experts and scholars from around the world every year to share and discuss innovative ideas and the latest scientific and clinical research findings…
-
Professor Baohui Han: Strategically Analyzing ASCO’s ADC Developments in NSCLC and Planning for Future Progress
On July 2, 2024, the “ADC High-Level Closed-Door Seminar,” chaired by Vice President Yong Yang of China Pharmaceutical University and President Jin Li of Shanghai Gaobo Oncology Hospital, was grandly held in Shanghai. The seminar explored the current status and future of ADC development. During the event, Oncology Frontier interviewed Professor Baohui Han from the…
-
EHA China’s Voice丨A New Perspective on Immune Escape in AML: Dr. Yang Liang’s Team Unveils the Regulatory Mechanism of FLT3-ITD
The 29th Annual Congress of the European Hematology Association (EHA) was grandly held in Madrid, Spain, from June 13 to 16, 2024. As the largest international conference in the field of hematology in Europe, it attracts experts and scholars from all over the world every year to share and discuss innovative ideas and the latest…
-
Professor Qian Jiang: Exploring New Models of Regional Academic Exchange, Beijing Hematology Academic Annual Meeting Concludes Successfully
On July 5th, the 17th Beijing Hematology Academic Annual Meeting, hosted by the Beijing Medical Association Hematology Branch, concluded successfully in Beijing. This year’s meeting featured innovative and unique formats and rich content, providing a platform for participants to share cutting-edge advancements and experiences. It also showcased the original research achievements in the field of…
Connecting Medical Expertise through Media